Wayne Foster
Chief Accounting Officer
Atea Pharmaceuticals, Inc. (AVIR)Equibles does not estimate personal net worth.
Get an email with a short summary when Atea Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AVIR alertsAbout Wayne Foster
Wayne Foster is recorded as Chief Accounting Officer at Atea Pharmaceuticals, Inc. (AVIR). The newest filing on record that lists Wayne Foster as Chief Accounting Officer at Atea Pharmaceuticals, Inc. (AVIR) is dated April 27, 2026. The proxy statement of Atea Pharmaceuticals, Inc. reports total compensation of $1,518,987 for Wayne Foster in fiscal 2023, including a base salary of $420,163. Atea Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Atea Pharmaceuticals, Inc. includes Jean-Pierre Sommadossi (CEO and Board Member), Andrea Corcoran (CFO), Arthur Kirsch (Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
Atea Pharmaceuticals, Inc. (AVIR)
Proxy statement
Start not stated–2021-04-29
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Atea Pharmaceuticals, Inc.
- Jean-Pierre Sommadossi CEO, Board Member
- Andrea Corcoran CFO
- Arthur Kirsch Board Member
- Barbara Duncan Board Member
- Bruce Polsky Board Member
- Bruno Lucidi Board Member
- Franklin Berger Board Member
- Howard Berman Board Member
- Howard H. Berman Board Member
- Jerome Adams Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Atea Pharmaceuticals, Inc. (AVIR) | Executive Vice President, Chief Accounting Officer | $420,163 | $1,518,987 |
Recent activity
No call appearances or filed executive changes recorded yet.